Personalization of targeted therapy in advanced thyroid cancer.
about
Any defining role of mast cell or mast cell density in oral squamous cell carcinoma?New therapies for dedifferentiated papillary thyroid cancerSelective use of vandetanib in the treatment of thyroid cancer.Lenvatinib: A Review in Refractory Thyroid Cancer.CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation.
P2860
Personalization of targeted therapy in advanced thyroid cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Personalization of targeted therapy in advanced thyroid cancer.
@en
type
label
Personalization of targeted therapy in advanced thyroid cancer.
@en
prefLabel
Personalization of targeted therapy in advanced thyroid cancer.
@en
P2093
P2860
P1433
P1476
Personalization of targeted therapy in advanced thyroid cancer.
@en
P2093
Alessandro Antonelli
Poupak Fallahi
Salvatore Benvenga
Silvia Martina Ferrari
Valeria Mazzi
P2860
P304
P356
10.2174/1389202915999140404101902
P50
P577
2014-06-01T00:00:00Z